9-Tetradecenoic acid, 1,1',1'',1'''-[(2R,14R)-5,8,11-trihydroxy-5,11-dioxido-4,6,10,12-tetraoxa-5,11-diophosphapentadecane-1,2,14,15-tetrayl] ester, sodium salt (1:2), (9Z,9'Z,9''Z,9'''Z)-

Request For Quotation
9-Tetradecenoic acid, 1,1',1'',1'''-[(2R,14R)-5,8,11-trihydroxy-5,11-dioxido-4,6,10,12-tetraoxa-5,11-diophosphapentadecane-1,2,14,15-tetrayl] ester, sodium salt (1:2), (9Z,9'Z,9''Z,9'''Z)- Basic information
Product Name:9-Tetradecenoic acid, 1,1',1'',1'''-[(2R,14R)-5,8,11-trihydroxy-5,11-dioxido-4,6,10,12-tetraoxa-5,11-diophosphapentadecane-1,2,14,15-tetrayl] ester, sodium salt (1:2), (9Z,9'Z,9''Z,9'''Z)-
Synonyms:9-Tetradecenoic acid, 1,1',1'',1'''-[(2R,14R)-5,8,11-trihydroxy-5,11-dioxido-4,6,10,12-tetraoxa-5,11-diophosphapentadecane-1,2,14,15-tetrayl] ester, sodium salt (1:2), (9Z,9'Z,9''Z,9'''Z)-;Cardiolipin (14:1/14:1/14:1/14:1) (sodium salt)
CAS:2260669-33-6
MF:C65H119NaO17P2
MW:1257.59
EINECS:
Product Categories:
Mol File:2260669-33-6.mol
9-Tetradecenoic acid, 1,1',1'',1'''-[(2R,14R)-5,8,11-trihydroxy-5,11-dioxido-4,6,10,12-tetraoxa-5,11-diophosphapentadecane-1,2,14,15-tetrayl] ester, sodium salt (1:2), (9Z,9'Z,9''Z,9'''Z)- Structure
9-Tetradecenoic acid, 1,1',1'',1'''-[(2R,14R)-5,8,11-trihydroxy-5,11-dioxido-4,6,10,12-tetraoxa-5,11-diophosphapentadecane-1,2,14,15-tetrayl] ester, sodium salt (1:2), (9Z,9'Z,9''Z,9'''Z)- Chemical Properties
storage temp. -20°C
solubility Chloroform: Soluble
form liquid
InChIKeyKMIXSFXJUMNKKR-IVOFNDPZSA-L
Safety Information
WGK Germany WGK 3
Hazard ClassificationsAcute Tox. 3 Inhalation
Acute Tox. 4 Oral
Aquatic Chronic 3
Carc. 2
Eye Irrit. 2
Repr. 2
Skin Irrit. 2
STOT RE 1
STOT SE 3
MSDS Information
9-Tetradecenoic acid, 1,1',1'',1'''-[(2R,14R)-5,8,11-trihydroxy-5,11-dioxido-4,6,10,12-tetraoxa-5,11-diophosphapentadecane-1,2,14,15-tetrayl] ester, sodium salt (1:2), (9Z,9'Z,9''Z,9'''Z)- Usage And Synthesis
UsesGlycerophospholipids act as regulators of various enzyme activities, and can be used as biological markers to indicate pathological states.
Biological ActivityCardiolipin and cytochrome c interaction determines the function of proteins involved in oxidative phosphorylation and apoptosis. Cardiolipin involved in proton uptake pathway maintains the structure of enzymes participating. Cardiolipin controls the mitochondrial function and membrane potential. It offers structural support for the inner mitochondrial membrane and proteins in it. Altered cardiolipin concentration and composition have been implicated in pathological conditions including ischemia, hypothyroidism, aging, heart failure and cardioskeletal myopathy.', 'TMCL (1,1μ,2,2μ-tetramyristoyl cardiolipin) bilayers are useful in generating multilamellar vesicles. Defects in the metabolic pathway of cardiolipin is associated with Barth syndrome patients. Liposomes of TMCL with 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and cholesterol are potential drug-delivery systems. TMCL displays temperature dependant thermotropic phase transitions.
9-Tetradecenoic acid, 1,1',1'',1'''-[(2R,14R)-5,8,11-trihydroxy-5,11-dioxido-4,6,10,12-tetraoxa-5,11-diophosphapentadecane-1,2,14,15-tetrayl] ester, sodium salt (1:2), (9Z,9'Z,9''Z,9'''Z)- Preparation Products And Raw materials
Tag:9-Tetradecenoic acid, 1,1',1'',1'''-[(2R,14R)-5,8,11-trihydroxy-5,11-dioxido-4,6,10,12-tetraoxa-5,11-diophosphapentadecane-1,2,14,15-tetrayl] ester, sodium salt (1:2), (9Z,9'Z,9''Z,9'''Z)-(2260669-33-6) Related Product Information
9-Octadecenoic acid (9Z)-, 1,1'-[(1R,13R)-4,7,10-trihydroxy-4,10-dioxido-1,13-bis[[(1-oxohexadecyl)oxy]methyl]-3,5,9,11-tetraoxa-4,10-diphosphatridecane-1,13-diyl] ester, sodium salt (1:2) 1',3'-bis[1,2-diMyristoyl-sn-glycero-3-phospho]-sn-glycerol (sodiuM salt) 9-Hexadecenoic acid, 1,1',1'',1'''-[(2R,14R)-5,8,11-trihydroxy-5,11-dioxido-4,6,10,12-tetraoxa-5,11-diophosphapentadecane-1,2,14,15-tetrayl] ester, sodium salt (1:2), (9Z,9'Z,9''Z,9'''Z)- Cardiolipin (CL), (sodiuM or aMMoniuM salt) (bovine) Octadecanoic acid, 5,8,11-trihydroxy-5,11-dioxido-4,6,10,12-tetraoxa-5,11-diphosphapentadecane-1,2,14,15-tetrayl ester, disodium salt, [R-(R*,R*)]- (9CI) Human IgG1, kappa Isotype Control